These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 14519044

  • 1. Safety of COX-2 inhibitors in asthma patients with aspirin hypersensitivity.
    West PM, Fernández C.
    Ann Pharmacother; 2003 Oct; 37(10):1497-501. PubMed ID: 14519044
    [Abstract] [Full Text] [Related]

  • 2. Safety of high-dose rofecoxib in patients with aspirin-exacerbated respiratory disease.
    Woessner KM, Simon RA, Stevenson DD.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):339-44. PubMed ID: 15521369
    [Abstract] [Full Text] [Related]

  • 3. Successful use of cyclooxygenase-2 inhibitor in a patient with aspirin-induced asthma.
    Marks F, Harrell K, Fischer R.
    South Med J; 2001 Feb; 94(2):256-7. PubMed ID: 11235048
    [Abstract] [Full Text] [Related]

  • 4. Aspirin and NSAID sensitivity.
    Stevenson DD.
    Immunol Allergy Clin North Am; 2004 Aug; 24(3):491-505, vii. PubMed ID: 15242723
    [Abstract] [Full Text] [Related]

  • 5. Management options for patients with aspirin and nonsteroidal antiinflammatory drug sensitivity.
    Knowles SR, Drucker AM, Weber EA, Shear NH.
    Ann Pharmacother; 2007 Jul; 41(7):1191-200. PubMed ID: 17609236
    [Abstract] [Full Text] [Related]

  • 6. The safety of celecoxib in patients with aspirin-sensitive asthma.
    Woessner KM, Simon RA, Stevenson DD.
    Arthritis Rheum; 2002 Aug; 46(8):2201-6. PubMed ID: 12209526
    [Abstract] [Full Text] [Related]

  • 7. Sensitivity to nonsteroidal anti-inflammatory drugs.
    Namazy JA, Simon RA.
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):542-50; quiz 550, 605. PubMed ID: 12487218
    [Abstract] [Full Text] [Related]

  • 8. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.
    Martín-García C, Hinojosa M, Berges P, Camacho E, García-Rodriguez R, Alfaya T.
    J Investig Allergol Clin Immunol; 2003 Dec; 13(1):20-5. PubMed ID: 12861847
    [Abstract] [Full Text] [Related]

  • 9. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM, Lindley C.
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [Abstract] [Full Text] [Related]

  • 10. Adverse Drug Events Involving COX-2 Inhibitors.
    Verrico MM, Weber RJ, McKaveney TP, Ansani NT, Towers AL.
    Ann Pharmacother; 2003 Sep; 37(9):1203-13. PubMed ID: 12921500
    [Abstract] [Full Text] [Related]

  • 11. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC.
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [Abstract] [Full Text] [Related]

  • 12. Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
    Gray PA, Warner TD, Vojnovic I, Del Soldato P, Parikh A, Scadding GK, Mitchell JA.
    Br J Pharmacol; 2002 Dec; 137(7):1031-8. PubMed ID: 12429575
    [Abstract] [Full Text] [Related]

  • 13. Safety risks for patients with aspirin-exacerbated respiratory disease after acute exposure to selective nonsteroidal anti-inflammatory drugs and COX-2 inhibitors: Meta-analysis of controlled clinical trials.
    Morales DR, Lipworth BJ, Guthrie B, Jackson C, Donnan PT, Santiago VH.
    J Allergy Clin Immunol; 2014 Jul; 134(1):40-5. PubMed ID: 24388008
    [Abstract] [Full Text] [Related]

  • 14. Safety of triflusal (antiplatelet drug) in patients with aspirin-exacerbated respiratory diseases.
    Fraj J, Valero A, Vives R, Pérez I, Borja J, Izquierdo I, Picado C.
    Allergy; 2008 Jan; 63(1):112-5. PubMed ID: 18053020
    [Abstract] [Full Text] [Related]

  • 15. [Specific inhibitors of cyclooxygenase type 2] ].
    Tomasová-Studýnková J.
    Vnitr Lek; 2002 May; 48(5):403-8. PubMed ID: 12061207
    [Abstract] [Full Text] [Related]

  • 16. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients.
    Senna G, Bilò MB, Antonicelli L, Schiappoli M, Crivellaro MA, Bonadonna P, Dama AR.
    Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003
    [Abstract] [Full Text] [Related]

  • 17. COX-2 selective non-steroidal anti-inflammatory drugs and cardiovascular disease.
    Ray WA, MacDonald TM, Solomon DH, Graham DJ, Avorn J.
    Pharmacoepidemiol Drug Saf; 2003 Jun; 12(1):67-70. PubMed ID: 12616850
    [No Abstract] [Full Text] [Related]

  • 18. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
    Wolfe F, Michaud K, Burke TA, Zhao SZ.
    J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
    [Abstract] [Full Text] [Related]

  • 19. Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
    Umar A, Boisseau M, Yusup A, Upur H, Bégaud B, Moore N.
    Fundam Clin Pharmacol; 2004 Oct; 18(5):559-63. PubMed ID: 15482377
    [Abstract] [Full Text] [Related]

  • 20. Reducing clinically significant gastrointestinal toxicity associated with nonsteroidal antiinflammatory drugs.
    Jacobsen RB, Phillips BB.
    Ann Pharmacother; 2004 Sep; 38(9):1469-81. PubMed ID: 15213313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.